Bio-Rad Laboratories | BIO - Marktkapitalisierung

Aktienkurs
299.02
Täglich Wechseln
7.93 2.72%
Monatlich
11.58%
Jährlich
26.34%
Q2 Prognose
271.63




Marktkapitalisierung Veränderung Datum
Abbott USD 165.59B 12.82B 2026-04
Agilent USD 37.86B 3.64B 2025-12
Becton, Dickinson and Co. USD 55.29B 1.64B 2025-12
Bio Techne USD 9.16B 502M 2025-12
Bio-Rad Laboratories USD 8.21B 601M 2025-12
Bruker USD 7.16B 2.23B 2025-12
Charles River Laboratories USD 10.02B 2.71B 2025-12
Danaher USD 161.7B 29.34B 2025-12
General Electric Aerospace USD 324.91B 5.91B 2025-12
Illumina USD 20.62B 6.53B 2025-12
IQVIA Holdings USD 38.39B 6.1B 2025-12
Laboratory Of America USD 20.8B 3.03B 2025-12
Merck USD 261.26B 51.62B 2025-12
Mettler Toledo International USD 28.48B 3.19B 2025-12
Myriad Genetics USD 575M 98M 2025-12
OraSure Technologies USD 174M 61M 2025-12
Pacific Biosciences Of California USD 565M 180M 2025-12
Quest Diagnostics USD 19.3B 2.01B 2025-12
Repligen USD 9.22B 1.7B 2025-12
Revvity USD 10.97B 1.21B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Siemens EUR 191.32B 7.96B 2025-12
Standard Biotools USD 492M 5M 2025-12
Thermo Fisher Scientific USD 217.7B 42.4B 2025-12
Tosoh JPY 764.59B 52.83B 2025-12
Waters USD 22.61B 5.25B 2025-12